Scientists attack pancreatic cancer with Triple-Threat immune therapy before surgery

NCT ID NCT06048484

Summary

This study tests whether adding new immune-boosting drugs to standard radiation before surgery can help the body fight advanced pancreatic cancer more effectively. It will enroll 60 patients who have already completed initial chemotherapy and are candidates for surgery. Researchers will compare different drug combinations to see which best activates the immune system against the tumor and improves surgical outcomes.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Columbia University Irving Medical Center

    RECRUITING

    New York, New York, 10032, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

    Contact Email: •••••@•••••

  • Northwell Health R.J. Zuckerberg Cancer Center

    RECRUITING

    Lake Success, New York, 11042, United States

    Contact Email: •••••@•••••

    Contact

  • UNC Hospitals, The University of North Carolina at Chapel Hill

    RECRUITING

    Chapel Hill, North Carolina, 27514, United States

    Contact Phone: •••-•••-••••

  • University of Pennsylvania, Abramson Cancer Center

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.